Showing results (331-340 of 387) with videos related to

Sort By:
Pageof 39
International Journal of Alzheimer'S Disease|May 12, 2011
Thickness in entorhinal and subicular cortex predicts episodic memory decline in mild cognitive impairmentA C Burggren, B Renner, M Jones, et al.
International Journal of Alzheimer'S Disease|May 12, 2011
Bioinformatics identification of modules of transcription factor binding sites in Alzheimer's disease-related genes by in silico promoter analysis and microarraysRegina Augustin, Stefan F Lichtenthaler, Michael Greeff, et al.
International Journal of Alzheimer'S Disease|May 12, 2011
Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE GeneFrancesco Panza, Davide Seripa, Grazia D'Onofrio, et al.
International Journal of Alzheimer'S Disease|May 12, 2011
Electromyographic activity in the EEG in Alzheimer's disease: noise or signal?Karin van der Hiele, Robert H A M Reijntjes, Alla A Vein, et al.
International Journal of Alzheimer'S Disease|December 23, 2011
On the involvement of copper binding to the N-terminus of the amyloid Beta Peptide of Alzheimer's disease: a computational study on model systemsSamira Azimi, Arvi Rauk
International Journal of Alzheimer'S Disease|January 19, 2012
Leptin: a novel therapeutic target in Alzheimer's disease?Dayne Beccano-Kelly, Jenni Harvey
International Journal of Alzheimer'S Disease|July 15, 2011
Morphological Factor Estimation via High-Dimensional Reduction: Prediction of MCI Conversion to Probable ADSimon Duchesne, Abderazzak Mouiha
International Journal of Alzheimer'S Disease|July 22, 2011
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylationDiane P Hanger, Wendy Noble
International Journal of Alzheimer'S Disease|July 26, 2011
Evaluating voting competence in persons with Alzheimer diseasePietro Tiraboschi, Erica Chitò, Leonardo Sacco, et al.
International Journal of Alzheimer'S Disease|June 2, 2011
Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE PathwayKatja Kanninen, Anthony R White, Jari Koistinaho, et al.
Pageof 39